Aamir Malik of Pfizer discusses the role of mRNA in vaccines and future drug development, partnerships, and the role of manufacturing in product innovation.
Autologous cell therapy for the treatment of ALS and PMS will be manufactured at Catalent’s 32,000 sq.-ft. cell therapy manufacturing facility in Houston.
This webcast will outline the typical steps Oakwood Labs takes during post-feasibility, scale-up, technology transfer, and Phase I clinical batch production.